Choose from Cartoon Of The People With Cirrhosis Liver stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature ...

The closure of the Centers for Disease Control and Prevention (CDC)’s Division of Viral Hepatitis in the wake of the administration’s restructuring of the Department of Health and Human ...

CDC Shuts Down Key Labs for Hepatitis and STI Testing After Layoffs MONDAY, April 21, 2025 (HealthDay News) — Key labs at the U.S. Centers for Disease Control and Prevention (CDC) have shut down ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical ...

These labs perform advanced disease testing and analysis on hepatitis to understand how it spreads, as well as track infections like chlamydia, syphilis, and gonorrhea. HealthDay News — Key labs ...

You’re all signed up! Want more of our free, weekly newsletters in your inbox? Let’s get started. The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a ...

This vaccine candidate uses technology that’s already being used in hepatitis B and human papillomavirus (HPV) vaccines.

Protein-based vaccines have been used for years to prevent other diseases including hepatitis B and shingles. Each year, the three manufacturers update their vaccine recipes to better match the ...

On World Liver Day, observed on April 19, Prime Minister Narendra Modi called for efforts to make the country fitter and healthier, through steps such as raising awareness about obesity and ...

The removals shut down the C.D.C.’s renowned viral-hepatitis lab in the middle of a hepatitis-C-outbreak investigation in Florida—just after C.D.C. staff had genetically traced the outbreak to ...

WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage ...

The following abstracts will be presented as posters in the Viral Hepatitis B and D: New Therapies, Unapproved Therapies or Strategies session on May 8, 2025, from 8:30 am - 5:00 pm CET. This will ...